Courtney DiNardo

288PUBLICATIONS
670CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (288)

|Aug 13, 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

|Aug 06, 2026
A quantitative definition of the clinical manifestations of GATA2 deficiency in adults.

|Jul 23, 2026
LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical Models.

|Jul 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Jun 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

Pageof 48

Frequent Collaborators

164 joint publications

Navel G Daver

147 joint publications

Tapan M Kadia

119 joint publications

Hagop M Kantarjian

107 joint publications

Guillermo Garcia-Manero